drugset / Trial / NCT02767479
Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori
RandomizedParallel-groupOpen-labelTreatment
Summary
Patients infected with H. pylori are treated with rabeprazole 10 mg bid, AMPC 750 mg bid and CAM 200 mg bid or esomeprazole 20 mg bid, AMPC 750 mg bid and CAM 200 mg bid. Eradication rates are compared. Patients who have ever failed in eradication by CAM-based regimen are treated with rabeprazole 10 mg bid, AMPC 750 mg bid and MNZ 250 mg bid or esomeprazole 20 mg bid, AMPC 750 mg bid and MNZ 250 mg bid.
Timeline
- Start
- 2012-07
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 20 mg | — |
| Comparator | Rabeprazole | Small molecule | 10 mg | — |
| Comparator | AMPC | Unknown | 750 mg | — |
| Comparator | CAM | Unknown | 200 mg | — |